2,497 publications from this institution
To increase datacenter energy efficiency, we need memory systems that keep pace with processor efficiency gains. Currently, servers use DDR3 memory, which is designed for high bandwidth but not for energy proportionality. A system using 20% of the peak DDR3 bandwidth consumes 2.3x the energy per bit compared to the energy consumed by a system with fully utilized memory bandwidth. Nevertheless, many datacenter applications stress memory capacity and latency but not memory bandwidth. In response, we architect server memory systems using mobile DRAM devices, trading peak bandwidth for lower energy consumption per bit and more efficient idle modes. We demonstrate 3-5x lower memory power, better proportionality, and negligible performance penalties for datacenter workloads.
Genomic and other related big data (Big Genomic Data, BGD for short) are ushering a new era of precision medicine. This overview discusses whether principles of evidence-based medicine hold true for BGD and how they should be operationalized in the current era. Major evidence-based medicine principles include the systematic identification, description and analysis of the validity and utility of BGD, the combination of individual clinical expertise with individual patient needs and preferences, and the focus on obtaining experimental evidence, whenever possible. BGD emphasize information of single patients with an overemphasis on N-of-1 trials to personalize treatment. However, large-scale comparative population data remain indispensable for meaningful translation of BGD personalized information. The impact of BGD on population health depends on its ability to affect large segments of the population. While several frameworks have been proposed to facilitate and standardize decision making for use of genomic tests, there are new caveats that arise from BGD that extend beyond the limitations that were applicable for more simple genetic tests. Non-evidence-based use of BGD may be harmful and result in major waste of healthcare resources. Randomized controlled trials will continue to be the strongest arbitrator for the clinical utility of genomic technologies, including BGD. Research on BGD needs to focus not only on finding robust predictive associations (clinical validity) but also more importantly on evaluating the balance of health benefits and potential harms (clinical utility), as well as implementation challenges. Appropriate features of such useful research on BGD are discussed.
Learning Objectives After completing this course, the reader will be able to: Discuss the current status of translational research on molecular profiling for cancer.Highlight the steps and difficulties and biases involved in moving molecular profiling from the bench to the bedside.Propose potential solutions to the challenges of clinical use of this new technology. CME Access and take the CME test online and receive 1 AMA PRA Category 1 Credit™ at CME.TheOncologist.com
China is undergoing a rapid transition from a rural to an urban society. This societal change is a consequence of a national drive toward economic prosperity. Rapid urbanization impacts on infrastructure, environmental health and human wellbeing. Unlike many cases of urban expansion, Chinese urbanization has led to containment, rather than to increase, in the spread of infectious diseases. Conversely, the incidence of chronic conditions such as cardiovascular and metabolic diseases has risen, with higher rates occurring in urban regions. This rural-urban gradient in disease incidence seems not to be a reflection simply of more aggressive diagnosis or healthcare access. Other diseases exhibit little rural versus urban differences (e.g., liver cancer or respiratory disease), or even occur at a higher rate in the rural population (e.g., esophageal cancer). This article examines the impact of this changing demographic on environmental health and human wellbeing in China. Lessons learned from epidemiological studies mostly carried out in Europe and the U.S. may not be directly transferable to China. We advocate that there is now a need to establish robust systems of accurate data collection, a Chinese biobank network to facilitate the profiling of human health effects, and relevant randomized controlled trials to identify effective interventions in the Chinese urbanized setting. Such studies could allow for the future implementation of disease-preventive strategies.
In this paper, we introduce the concept of tiles. Tiles are incorporated into the current design of the High Efficiency Video Coding (HEVC) standard being developed by the Joint Collaborative Team on Video Coding (JCT-VC). In the design, tiles are introduced to support high-level parallelism and also to reduce on-chip memory requirements. This paper describes the tile concept and reports results due to the technique.
Much of the published medical research is apparently flawed, cannot be replicated and/or has limited or no utility. This article presents an overview of the current landscape of biomedical research, identifies problems associated with common study designs and considers potential solutions. Randomized clinical trials, observational studies, systematic reviews and meta-analyses are discussed in terms of their inherent limitations and potential ways of improving their conduct, analysis and reporting. The current emphasis on statistical significance needs to be replaced by sound design, transparency and willingness to share data with a clear commitment towards improving the quality and utility of clinical research.
The architecture of a 64.5K transistor chip that generates 192 test vectors and compares them witll data returned by a 16-pin device under test, will be described. It is implemented in 3μm CMOS, with a die size of 9.2×7.9mm. Dissipation is 300mW at a 10MHz clock rate.